Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated treatment of infectious endocarditis
2022-001894-29Phase 4Active
- Sponsor
- Lund University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ampicillin in endocarditis (IE), sponsored by Lund University. Primary endpoint: All-cause mortality. Started Dec 2022; status: active.
02
Drugs
ampicillin
03
Conditions
endocarditis (IE)
Beyond the preview
Go deeper on 2022-001894-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001894-29.